Aterian (NASDAQ:ATER) Stock Rating Lowered by Wall Street Zen

Aterian (NASDAQ:ATERGet Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings raised shares of Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 19th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Read Our Latest Analysis on Aterian

Aterian Trading Down 27.1%

ATER opened at $0.40 on Friday. The business has a 50 day moving average of $1.18 and a 200-day moving average of $0.88. The stock has a market capitalization of $4.36 million, a price-to-earnings ratio of -0.16 and a beta of 0.68. Aterian has a 1-year low of $0.40 and a 1-year high of $1.87.

Aterian (NASDAQ:ATERGet Free Report) last released its earnings results on Friday, May 15th. The company reported ($0.39) EPS for the quarter, beating the consensus estimate of ($0.69) by $0.30. The firm had revenue of $0.02 million during the quarter, compared to analysts’ expectations of $15.82 million. Aterian had a negative net margin of 39.56% and a negative return on equity of 82.05%.

Institutional Investors Weigh In On Aterian

Hedge funds have recently made changes to their positions in the company. Citadel Advisors LLC raised its holdings in Aterian by 222.0% during the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after purchasing an additional 22,865 shares during the last quarter. Susquehanna International Group LLP lifted its holdings in Aterian by 310.2% in the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after buying an additional 30,637 shares during the period. Goldman Sachs Group Inc. boosted its stake in Aterian by 73.0% in the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after acquiring an additional 9,026 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in Aterian during the 2nd quarter worth $55,000. Institutional investors and hedge funds own 7.02% of the company’s stock.

About Aterian

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Recommended Stories

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.